2006 annual financial data

Regeneron Pharmaceuticals, Inc. 2006 Operating margin

Regeneron Pharmaceuticals, Inc. 2006 operating margin with verified reported va…

Direct answer

Operating margin was -169.13%.

Operating income was -107,307,000 USD and net income was -102,337,000 USD.
Operating cash flow was 23,075,000 USD.

Get free Regeneron Pharmaceuticals, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
63,447,000 USD
Operating income
-107,307,000 USD
Net income
-102,337,000 USD
Operating cash flow
23,075,000 USD